Literature DB >> 16153206

Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy.

John E McCabe1, Abdullah Jibawi, Pradip Javle.   

Abstract

OBJECTIVE: To define 'high-' and 'low-' volume hospitals for radical cystectomy, and the minimum caseload required for a hospital to achieve optimum outcomes, as a relationship between increasing surgical case volume and improved outcomes in radical urological surgery has been suggested in recent North American studies.
METHODS: All cystectomies for urological cancer in England over 5 years were analysed from Hospital Episode Statistics (HES) data. The data were analysed statistically to describe the relationship between each hospital's annual case volume and two outcome measures: in-hospital mortality rate (MR) and hospital stay.
RESULTS: In all, there were 6317 cystectomies in 210 centres, with an overall MR of 5.6%. There was a significant inverse correlation (-0.733, P < 0.01) between hospital case volume and MR. Applying 95% confidence intervals, the minimum caseload required to achieve optimum outcomes was 11 procedures/year. Increasing the caseload beyond this minimum did not produce a significant reduction in MR.
CONCLUSION: Analysis of HES data confirms an inverse relationship between hospital caseload and mortality for radical cystectomy. A caseload of 11 operations/year is associated with the lowest MR.

Entities:  

Mesh:

Year:  2005        PMID: 16153206     DOI: 10.1111/j.1464-410X.2005.05717.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  Patient-reported outcomes for patients undergoing radical cystectomy: a prospective case-control study.

Authors:  Catharina A Goossens-Laan; Paul J M Kil; J L H Ruud Bosch; Jolanda De Vries
Journal:  Support Care Cancer       Date:  2013-09-13       Impact factor: 3.603

2.  Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomes.

Authors:  John E McCabe; Abdullah Jibawi; Pradip M Javle
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

3.  Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol.

Authors:  Peter Declercq; Gunter De Win; Frank Van der Aa; Elodie Beels; Beels Elodie; Lorenz Van der Linden; Hendrik Van Poppel; Ludo Willems; Willems Ludo; Isabel Spriet; Spriet Isabel
Journal:  Int J Clin Pharm       Date:  2015-02-10

4.  Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.

Authors:  Lujia Wang; Minwei Zhou; Chenchen Feng; Peng Gao; Guanxiong Ding; Zhongwen Zhou; Haowen Jiang; Zhong Wu; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

5.  Impact of provider volume on operative mortality after radical cystectomy in a publicly funded healthcare system.

Authors:  Girish S Kulkarni; David R Urbach; Peter C Austin; Neil E Fleshner; Andreas Laupacis
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

Review 6.  Improving outcomes with radical cystectomy for high-grade invasive bladder cancer.

Authors:  John P Stein
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

7.  Impact of an oral nutrition protocol in patients treated with elective radical cystectomy: a long term follow-up.

Authors:  Peter Declercq; Frank Van der Aa; Lutgart De Pourcq; Isabel Spriet
Journal:  Int J Clin Pharm       Date:  2019-03-12

8.  The volume-mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics.

Authors:  Erik K Mayer; Alex Bottle; Ara W Darzi; Thanos Athanasiou; Justin A Vale
Journal:  BMJ       Date:  2010-03-19

9.  Hospital Episode Statistics and trends in ophthalmic surgery 1998-2004.

Authors:  Lucy C Clarke; Scott G Fraser
Journal:  BMC Ophthalmol       Date:  2006-12-04       Impact factor: 2.209

Review 10.  Does practice make perfect?

Authors:  A M Hogan; D C Winter
Journal:  Ann Surg Oncol       Date:  2008-01-29       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.